CDXS logo

Codexis (CDXS)

Profile

Full Name

Codexis, Inc.

Ticker Symbol

CDXS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 22, 2010

Indexes

Not included

Website

http://www.codexis.com

Employees

188

Key Details

Price

$2.11(-0.47%)

Market cap

$174.79M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$59.34M(-15.39% YoY)

Annual EPS

-$0.89(+20.54% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.11
CDXS price is $2.11

30-Day Relative Volume

0.51
CDXS 30-day relative volume is 0.51

Price Performance

Price Most recent change

-0.47%
CDXS price was down -0.47% on Apr 17, 2025

Price YTD change

-55.77%
CDXS price is down -55.77% since January 1st

Price 1-year change

-23.55%
CDXS price is down -23.55% year-on-year

Price 3-year change

-88.53%
CDXS price is down -88.53% over the past 3 years

Price Range

Price All-time high

$42.01
CDXS price is currently -94.98% below its historical high of $42.01

Price 3-year low

$1.45
CDXS price is currently +45.52% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$174.79M
CDXS market capitalization is $174.79 million

Market cap 3-year change

-85.45%
CDXS market capitalization is down -85.45% over the past 3 years

Market cap All-time high

$2.71B
CDXS market capitalization is currently -93.55% below its historical high of $2.71 billion

Market cap sector rank

55.31%
CDXS market capitalization is higher than 55.31% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.41%
CDXS shares outstanding is up +17.41% year-on-year

Shares Outstanding 3-Year Change

+26.85%
CDXS shares outstanding is up +26.85% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.64
CDXS beta is 1.64

200-day SMA

$3.60
CDXS price is currently -41.40% below its 200-day simple moving average

50-day SMA

$3.06
CDXS price is currently -30.97% below its 50-day simple moving average

RSI

35.94
CDXS 14-day relative strength index is 35.94

Volume

0.51
CDXS 30-day relative volume is 0.51

ATR

$0.22
CDXS average true range is $0.22

10-day Historical Volatility

111.29%
CDXS 10-day historical volatility is 111.29%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$59.34M
CDXS annual revenue is $59.34 million

Revenue Analysts estimate

$65.53M
CDXS annual revenue is currently -9.43% lower than the consensus analysts' forecast

Revenue 1-year change

-15.39%
CDXS annual revenue is down -15.39% year-on-year

Revenue Sector rank

49.44%
CDXS annual revenue is higher than 49.44% of companies in Healthcare sector

EPS

EPS

-$0.89
CDXS annual earnings per share is -$0.89

EPS Analysts estimate

-$0.58
CDXS annual earnings per share is currently +52.14% higher than the consensus analysts' forecast

EPS 1-year change

+20.54%
CDXS annual earnings per share is up +20.54% year-on-year

EPS Sector rank

59.07%
CDXS annual earnings per share is higher than 59.07% of companies in Healthcare sector

Profit

Gross profit

$43.06M
CDXS annual gross profit is $43.06 million

Gross margin

72.55%
CDXS annual gross profit margin is 72.55%

Operating profit

-$58.35M
CDXS annual operating income is -$58.35 million

Operating margin

-98.33%
CDXS annual operating profit margin is -98.33%

Net income

-$65.28M
CDXS annual net profit is -$65.28 million

Net margin

-109.99%
CDXS annual net profit margin is -109.99%

Expenses

Total expenses

$117.70M
CDXS annual total expenses is $117.70 million

Operating expenses

$101.41M
CDXS annual total operating expenses is $101.41 million

Cost of goods sold

$16.29M
CDXS annual cost of goods sold is $16.29 million

Selling, general & administrative expenses

$55.15M
CDXS annual SGA is $55.15 million

Depreciation and amortization

$4.95M
CDXS annual depreciation & amortization is $4.95 million

Interest expense

-
CDXS annual interest expense value is unknown

Income tax

$34.00K
CDXS annual income tax is $34.00 thousand

EBIT & EBITDA

EBIT

-$58.35M
CDXS annual earnings before interest & taxes is -$58.35 million

EBITDA

-$53.41M
CDXS annual EBITDA is -$53.41 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$149.01M
CDXS annual total assets is $149.01 million

Non current assets

$50.24M
CDXS annual long term assets is $50.24 million

Current assets

$98.77M
CDXS annual total current assets is $98.77 million

Cash and cash equivalents

$19.26M
CDXS annual cash & cash equivalents is $19.26 million

Accounts receivable

$11.92M
CDXS annual accounts receivable is $11.92 million

Inventory

$1.80M
CDXS annual inventory is $1.80 million

Liabilities

Total liabilities

$82.08M
CDXS annual total liabilities is $82.08 million

Long term liabilities

$58.44M
CDXS annual total long term liabilities is $58.44 million

Current liabilities

$23.65M
CDXS annual total current liabilities is $23.65 million

Accounts payable

$2.84M
CDXS annual accounts payable is $2.84 million

Debt

Total debt

$59.90M
CDXS annual total debt is $59.90 million

Total debt 1-year change

+273.78%
CDXS annual total debt is up +273.78% year-on-year

Long term debt

$57.07M
CDXS annual long term debt is $57.07 million

Short term debt

$2.83M
CDXS annual short term debt is $2.83 million

Equity & Capital

Shareholders equity

$66.93M
CDXS annual stockholders equity is $66.93 million

Book value

$66.93M
CDXS annual book value is $66.93 million

Retained earnings

-$562.81M
CDXS annual retained earnings is -$562.81 million

Working capital

$75.12M
CDXS annual working capital is $75.12 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$49.41M
CDXS annual cash flow from operations is -$49.41 million

Cash from operations 1-year change

+6.13%
CDXS annual cash flow from operations is up +6.13% year-on-year

Cash from investing

-$56.98M
CDXS annual cash flow from investing activities is -$56.98 million

Cash from investing 1-year change

-1072.91%
CDXS annual cash flow from investing activities is down -1072.91% year-on-year

Cash from financing

$60.52M
CDXS annual cash flow from financing activities is $60.52 million

Cash from financing 1-year change

+641.06%
CDXS annual cash flow from financing activities is up +641.06% year-on-year

CAPEX

CAPEX

$4.30M
CDXS annual capital expenditures is $4.30 million

CAPEX 1-year change

-2.56%
CDXS annual capital expenditures is down -2.56% year-on-year

Free Cash Flow

Free cash flow

-$53.72M
CDXS annual free cash flow is -$53.72 million

Free cash flow 1-year change

+5.86%
CDXS annual free cash flow is up +5.86% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

72.55%
CDXS annual gross profit margin is 72.55%

Operating margin

-98.33%
CDXS annual operating profit margin is -98.33%

Net margin

-109.99%
CDXS annual net profit margin is -109.99%

ROA & ROE

ROA

-45.72%
CDXS annual return on assets is -45.72%

ROE

-85.03%
CDXS annual return on equity is -85.03%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CDXS price to earnings ratio value is unknown

PE ratio Sector rank

-
CDXS price to earnings ratio is unknown

PB Ratio

PB ratio

2.61
CDXS price to book ratio is 2.61

PB ratio Sector rank

69.66%
CDXS price to book ratio is higher than 69.66% of companies in Healthcare sector

PS Ratio

PS ratio

2.95
CDXS price to sales ratio is 2.95

PS ratio Sector rank

51.73%
CDXS price to sales ratio is higher than 51.73% of companies in Healthcare sector

Enterprise value

Enterprise value

$215.42M
CDXS enterprise value is $215.42 million

Enterprise value Sector rank

59.92%
CDXS enterprise value is higher than 59.92% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.05
CDXS EV/EBITDA is -4.05

EV/EBITDA Sector rank

21.24%
CDXS EV/EBITDA is higher than 21.24% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.18
CDXS annual current ratio is 4.18

Quick ratio

4.10
CDXS annual quick ratio is 4.10

Leverage

Debt to equity

0.43
CDXS annual debt to equity ratio is 0.43

Interest coverage ratio

-
CDXS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
CDXS piotroski f-score is 3

Altman Z-Score

-4.30
CDXS altman z-score is -4.30

Analyst ratings

Recent major analysts updates

Nov 22, 24 Cantor Fitzgerald
Overweight
Nov 15, 24 Cantor Fitzgerald
Overweight
Nov 4, 24 Benchmark
Hold
Sep 20, 24 Cantor Fitzgerald
Overweight
Aug 29, 24 Cantor Fitzgerald
Overweight
Aug 19, 24 Benchmark
Hold
Aug 9, 24 Cantor Fitzgerald
Overweight
May 30, 24 Cantor Fitzgerald
Overweight
May 3, 24 Benchmark
Buy
Feb 29, 24 Benchmark
Buy

Institutional Ownership

Similar stocks

VYGR logo
Voyager Therapeutics (VYGR)
GNFT logo
Genfit SA (GNFT)
American Oncology Network (AONC)
FULC logo
Fulcrum Therapeutics (FULC)
UTMD logo
Utah Medical Products (UTMD)
NGNE logo
Neurogene (NGNE)
ELDN logo
Eledon Pharmaceuticals (ELDN)
TriSalus Life Sciences (TLSI)
LUNG logo
Pulmonx (LUNG)
  • What is the ticker symbol for Codexis?
  • Does Codexis pay dividends?
  • What sector is Codexis in?
  • What industry is Codexis in?
  • What country is Codexis based in?
  • When did Codexis go public?
  • Is Codexis in the S&P 500?
  • Is Codexis in the NASDAQ 100?
  • Is Codexis in the Dow Jones?
  • When was Codexis's last earnings report?
  • When does Codexis report earnings?
  • Should I buy Codexis stock now?

What is the ticker symbol for Codexis?

The ticker symbol for Codexis is NASDAQ:CDXS

Does Codexis pay dividends?

No, Codexis does not pay dividends

What sector is Codexis in?

Codexis is in the Healthcare sector

What industry is Codexis in?

Codexis is in the Biotechnology industry

What country is Codexis based in?

Codexis is headquartered in United States

When did Codexis go public?

Codexis's initial public offering (IPO) was on April 22, 2010

Is Codexis in the S&P 500?

No, Codexis is not included in the S&P 500 index

Is Codexis in the NASDAQ 100?

No, Codexis is not included in the NASDAQ 100 index

Is Codexis in the Dow Jones?

No, Codexis is not included in the Dow Jones index

When was Codexis's last earnings report?

Codexis's most recent earnings report was on Feb 27, 2025

When does Codexis report earnings?

The next expected earnings date for Codexis is May 2, 2025

Should I buy Codexis stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page